Last 12 months
Inside the activity.
0 purchase rows · 40 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 15 |
| Jul 2026 | 0 | 6 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 12, 2020 Filed Nov 16, 2020 23:11 UTC |
Gano KyleChief Business Development Off
|
SaleCommon Stock | 2,257 | $90.73 | $204,770.39 |
DisclosureSEC source: 0001209191-20-058543 · doc4.xml · nonDerivative · entry 1 Gano Kyle · CIK 0001567160 · Chief Business Development Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,028 F1 · kind: Sale of 2,257 shares of common stock issued upon vesting of 4,288 performance restricted stock units to cover withholding taxes, with the balance of the shares (2,031) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $88.93 to $92.23. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 23:08 UTC |
Bozigian Haig P.Chief Development Officer
|
SaleCommon Stock | 2,257 | $90.74 | $204,806.50 |
DisclosureSEC source: 0001209191-20-058539 · doc4.xml · nonDerivative · entry 1 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,694 F1 · kind: Sale of 2,257 shares of common stock issued upon vesting of 4,288 performance restricted stock units to cover withholding taxes, with the balance of the shares (2,031) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $88.93 to $92.23. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 23:02 UTC |
ABERNETHY MATTChief Financial Officer
|
SaleCommon Stock | 2,257 | $90.74 | $204,810.11 |
DisclosureSEC source: 0001209191-20-058532 · doc4.xml · nonDerivative · entry 1 ABERNETHY MATT · CIK 0001724097 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,014 F1 · kind: Sale of 2,257 shares of common stock issued upon vesting of 4,288 performance restricted stock units to cover withholding taxes, with the balance of the shares (2,031) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $88.93 to $92.23. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 23:09 UTC |
BENEVICH ERICChief Commercial Officer
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 20,595 | $35.99 Strike: $35.99 | $741,214.05 |
DisclosureSEC source: 0001209191-20-056981 · doc4.xml · derivative · entry 3 BENEVICH ERIC · CIK 0001643653 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,775 Underlying: Common Stock · 20,595 shares Expires 2026-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option granted February 05, 2016 and vested monthly over four years. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 23:09 UTC |
BENEVICH ERICChief Commercial Officer
|
SaleCommon Stock | 20,595 | $96.53 | $1,987,971.51 |
DisclosureSEC source: 0001209191-20-056981 · doc4.xml · nonDerivative · entry 2 BENEVICH ERIC · CIK 0001643653 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,374 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $94.68 to $98.80. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 23:09 UTC |
BENEVICH ERICChief Commercial Officer
|
Exercise / conversionCommon Stock | 20,595 | $35.99 | $741,214.05 |
DisclosureSEC source: 0001209191-20-056981 · doc4.xml · nonDerivative · entry 1 BENEVICH ERIC · CIK 0001643653 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 20:05 UTC |
Cooke JulieChief Human Resources Officer
|
SaleCommon Stock | 987 | $95.26 | $94,021.62 |
DisclosureSEC source: 0001209191-20-053998 · doc4.xml · nonDerivative · entry 1 Cooke Julie · CIK 0001776977 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,549 F1 · kind: Sale of 987 shares of common stock issued upon vesting of 1,875 restricted stock units on October 2, 2020 to cover payroll and withholding taxes, with the balance of the shares (888) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 23:51 UTC |
ROBERTS EIRYChief Medical Officer
|
SaleCommon Stock | 2,257 | $118.84 | $268,225.27 |
DisclosureSEC source: 0001209191-20-045771 · doc4.xml · nonDerivative · entry 1 ROBERTS EIRY · CIK 0001727606 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,446 F1 · kind: Sale of 2,257 shares of common stock issued upon vesting of 4,287 performance restricted stock units to cover withholding taxes, with the balance of the shares (2,030) maintained by the Reporting Person. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $118.21 to $120.56. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 23:47 UTC |
Lloyd-Smith MalcolmChief Regulatory Officer
|
SaleCommon Stock | 2,257 | $118.86 | $268,277.40 |
DisclosureSEC source: 0001209191-20-045767 · doc4.xml · nonDerivative · entry 1 Lloyd-Smith Malcolm · CIK 0001557146 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,971 F1 · kind: Sale of 2,257 shares of common stock issued upon vesting of 4,287 performance restricted stock units to cover withholding taxes, with the balance of the shares (2,030) maintained by the Reporting Person. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $118.21 to $120.56. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 23:40 UTC |
Lippoldt DarinChief Legal Officer
|
SaleCommon Stock | 2,257 | $118.87 | $268,297.26 |
DisclosureSEC source: 0001209191-20-045763 · doc4.xml · nonDerivative · entry 1 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,051 F1 · kind: Sale of 2,257 shares of common stock issued upon vesting of 4,287 performance restricted stock units to cover withholding taxes, with the balance of the shares (2,030) maintained by the Reporting Person. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $118.21 to $120.45. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 23:36 UTC |
Grigoriadis Dimitri E.Chief Research Officer
|
SaleCommon Stock | 2,257 | $118.83 | $268,199.76 |
DisclosureSEC source: 0001209191-20-045758 · doc4.xml · nonDerivative · entry 1 Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,593 F1 · kind: Sale of 2,257 shares of common stock issued upon vesting of 4,287 performance restricted stock units to cover withholding taxes, with the balance of the shares (2,030) maintained by the Reporting Person. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $118.29 to $120.56. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 23:29 UTC |
GORMAN KEVIN CHARLESDirector · Chief Executive Officer
|
SaleCommon Stock | 3,390 | $118.91 | $403,101.17 |
DisclosureSEC source: 0001209191-20-045753 · doc4.xml · nonDerivative · entry 1 GORMAN KEVIN CHARLES · CIK 0001201096 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 438,021 F1 · kind: Sale of 3,390 shares of common stock issued upon vesting of 6,440 performance restricted stock units to cover withholding taxes, with the balance of the shares (3,050) maintained by the Reporting Person. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $118.16 to $120.76. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 23:24 UTC |
Gano KyleChief Business Development Off
|
SaleCommon Stock | 2,257 | $118.87 | $268,285.53 |
DisclosureSEC source: 0001209191-20-045749 · doc4.xml · nonDerivative · entry 1 Gano Kyle · CIK 0001567160 · Chief Business Development Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,997 F1 · kind: Sale of 2,257 shares of common stock issued upon vesting of 4,287 performance restricted stock units to cover withholding taxes, with the balance of the shares (2,030) maintained by the Reporting Person. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $118.21 to $120.56. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 23:21 UTC |
Cooke JulieChief Human Resources Officer
|
SaleCommon Stock | 2,257 | $118.91 | $268,382.80 |
DisclosureSEC source: 0001209191-20-045747 · doc4.xml · nonDerivative · entry 1 Cooke Julie · CIK 0001776977 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,661 F1 · kind: Sale of 2,257 shares of common stock issued upon vesting of 4,287 performance restricted stock units to cover withholding taxes, with the balance of the shares (2,030) maintained by the Reporting Person. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $118.21 to $120.56. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 23:14 UTC |
Bozigian Haig P.Chief Development Officer
|
SaleCommon Stock | 2,257 | $118.89 | $268,324.35 |
DisclosureSEC source: 0001209191-20-045742 · doc4.xml · nonDerivative · entry 1 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,663 F1 · kind: Sale of 2,257 shares of common stock issued upon vesting of 4,287 performance restricted stock units to cover withholding taxes, with the balance of the shares (2,030) maintained by the Reporting Person. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $118.34 to $120.56. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 22:35 UTC |
BENEVICH ERICChief Commercial Officer
|
SaleCommon Stock | 2,257 | $118.85 | $268,254.16 |
DisclosureSEC source: 0001209191-20-045725 · doc4.xml · nonDerivative · entry 1 BENEVICH ERIC · CIK 0001643653 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,374 F1 · kind: Sale of 2,257 shares of common stock issued upon vesting of 4,287 performance restricted stock units to cover withholding taxes, with the balance of the shares (2,030) maintained by the Reporting Person. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $118.21 to $120.56. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 22:22 UTC |
ABERNETHY MATTChief Financial Officer
|
SaleCommon Stock | 2,257 | $118.90 | $268,355.95 |
DisclosureSEC source: 0001209191-20-045716 · doc4.xml · nonDerivative · entry 1 ABERNETHY MATT · CIK 0001724097 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,983 F1 · kind: Sale of 2,257 shares of common stock issued upon vesting of 4,287 performance restricted stock units to cover withholding taxes, with the balance of the shares (2,030) maintained by the Reporting Person. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $118.29 to $120.71. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| July 09, 2020 Filed Jul 10, 2020 20:26 UTC |
Lippoldt DarinChief Legal Officer
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 1,657 | $35.99 Strike: $35.99 | $59,635.43 |
DisclosureSEC source: 0001209191-20-042167 · doc4.xml · derivative · entry 3 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,194 Underlying: Common Stock · 1,657 shares Expires 2026-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option granted February 5, 2016 and vested monthly over four years. Read SEC document |
| July 09, 2020 Filed Jul 10, 2020 20:26 UTC |
Lippoldt DarinChief Legal Officer
|
SaleCommon Stock | 1,657 | $136.02 | $225,385.80 |
DisclosureSEC source: 0001209191-20-042167 · doc4.xml · nonDerivative · entry 2 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,021 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $136.00 to $136.12. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| July 09, 2020 Filed Jul 10, 2020 20:26 UTC |
Lippoldt DarinChief Legal Officer
|
Exercise / conversionCommon Stock | 1,657 | $35.99 | $59,635.43 |
DisclosureSEC source: 0001209191-20-042167 · doc4.xml · nonDerivative · entry 1 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,678 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 20:19 UTC |
ROBERTS EIRYChief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 5,000 | $77.81 Strike: $77.81 | $389,050.00 |
DisclosureSEC source: 0001209191-20-038896 · doc4.xml · derivative · entry 3 ROBERTS EIRY · CIK 0001727606 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,860 Underlying: Common Stock · 5,000 shares Expires 2028-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option granted January 8, 2018 and vests at 25% upon first anniversary (January 8, 2019) and remaining 75% vesting in 36 equal monthly installments beginning February 8, 2019. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 20:19 UTC |
ROBERTS EIRYChief Medical Officer
|
SaleCommon Stock | 5,000 | $130.00 | $650,000.00 |
DisclosureSEC source: 0001209191-20-038896 · doc4.xml · nonDerivative · entry 2 ROBERTS EIRY · CIK 0001727606 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,416 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 20:19 UTC |
ROBERTS EIRYChief Medical Officer
|
Exercise / conversionCommon Stock | 5,000 | $77.81 | $389,050.00 |
DisclosureSEC source: 0001209191-20-038896 · doc4.xml · nonDerivative · entry 1 ROBERTS EIRY · CIK 0001727606 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 20:15 UTC |
Lippoldt DarinChief Legal Officer
|
Exercise / conversionIncentive Stock Option · Derivative | 5,000 | $32.99 Strike: $32.99 | $164,950.00 |
DisclosureSEC source: 0001209191-20-038890 · doc4.xml · derivative · entry 3 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2025-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option granted February 3, 2015 and vested monthly over four years. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 20:15 UTC |
Lippoldt DarinChief Legal Officer
|
SaleCommon Stock | 5,000 | $130.00 | $650,000.00 |
DisclosureSEC source: 0001209191-20-038890 · doc4.xml · nonDerivative · entry 2 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,021 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 20:15 UTC |
Lippoldt DarinChief Legal Officer
|
Exercise / conversionCommon Stock | 5,000 | $32.99 | $164,950.00 |
DisclosureSEC source: 0001209191-20-038890 · doc4.xml · nonDerivative · entry 1 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,021 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 21:31 UTC |
Grigoriadis Dimitri E.Chief Research Officer
|
Exercise / conversionIncentive Stock Option · Derivative | 1,049 | $43.24 Strike: $43.24 | $45,358.76 |
DisclosureSEC source: 0001209191-20-036698 · doc4.xml · derivative · entry 6 Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,151 Underlying: Common Stock · 1,049 shares Expires 2027-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option granted February 6, 2017 and vests monthly over four years. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 21:31 UTC |
Grigoriadis Dimitri E.Chief Research Officer
|
Exercise / conversionIncentive Stock Option · Derivative | 1,812 | $35.99 Strike: $35.99 | $65,213.88 |
DisclosureSEC source: 0001209191-20-036698 · doc4.xml · derivative · entry 5 Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,812 shares Expires 2026-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option granted February 5, 2016 and vested monthly over four years. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 21:31 UTC |
Grigoriadis Dimitri E.Chief Research Officer
|
Exercise / conversionIncentive Stock Option · Derivative | 2,710 | $32.99 Strike: $32.99 | $89,402.90 |
DisclosureSEC source: 0001209191-20-036698 · doc4.xml · derivative · entry 4 Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,710 shares Expires 2025-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option granted February 3, 2015 and vested monthly over four years. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 21:31 UTC |
Grigoriadis Dimitri E.Chief Research Officer
|
Exercise / conversionCommon Stock | 1,049 | $43.24 | $45,358.76 |
DisclosureSEC source: 0001209191-20-036698 · doc4.xml · nonDerivative · entry 3 Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 21:31 UTC |
Grigoriadis Dimitri E.Chief Research Officer
|
Exercise / conversionCommon Stock | 1,812 | $35.99 | $65,213.88 |
DisclosureSEC source: 0001209191-20-036698 · doc4.xml · nonDerivative · entry 2 Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 21:31 UTC |
Grigoriadis Dimitri E.Chief Research Officer
|
Exercise / conversionCommon Stock | 2,710 | $32.99 | $89,402.90 |
DisclosureSEC source: 0001209191-20-036698 · doc4.xml · nonDerivative · entry 1 Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2020 Filed May 20, 2020 22:59 UTC |
Grigoriadis Dimitri E.Chief Research Officer
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 10,000 | $35.99 Strike: $35.99 | $359,900.00 |
DisclosureSEC source: 0001209191-20-031028 · doc4.xml · derivative · entry 7 Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,588 Underlying: Common Stock · 10,000 shares Expires 2026-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option granted February 5, 2016 and vested monthly over four years. Read SEC document |
| May 19, 2020 Filed May 20, 2020 22:59 UTC |
Grigoriadis Dimitri E.Chief Research Officer
|
SaleCommon Stock | 32,749 | $126.73 | $4,150,133.40 |
DisclosureSEC source: 0001209191-20-031028 · doc4.xml · nonDerivative · entry 5 Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,992 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $125.91 to $127.25. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 19, 2020 Filed May 20, 2020 22:59 UTC |
Grigoriadis Dimitri E.Chief Research Officer
|
SaleCommon Stock | 10,000 | $125.98 | $1,259,800.00 |
DisclosureSEC source: 0001209191-20-031028 · doc4.xml · nonDerivative · entry 4 Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,741 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
| May 19, 2020 Filed May 20, 2020 22:59 UTC |
Grigoriadis Dimitri E.Chief Research Officer
|
Exercise / conversionCommon Stock | 10,000 | $35.99 | $359,900.00 |
DisclosureSEC source: 0001209191-20-031028 · doc4.xml · nonDerivative · entry 3 Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2020 Filed May 21, 2020 23:00 UTC |
SHERWIN STEPHEN ADirector
|
GrantNon-Qualified Stock Option · Derivative | 6,018 | $0.00 Strike: $119.93 | $0.00 |
DisclosureSEC source: 0001209191-20-031502 · doc4.xml · derivative · entry 1 SHERWIN STEPHEN A · CIK 0001079462 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,018 Underlying: Common Stock · 6,018 shares Expires 2030-05-19 F1 · derivative.exercise_date: Option vests in 12 equal monthly installments beginning June 19, 2020. Read SEC document |
| May 19, 2020 Filed May 21, 2020 22:59 UTC |
POPS RICHARD FDirector
|
GrantNon-Qualified Stock Option · Derivative | 6,018 | $0.00 Strike: $119.93 | $0.00 |
DisclosureSEC source: 0001209191-20-031499 · doc4.xml · derivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,018 Underlying: Common Stock · 6,018 shares Expires 2030-05-19 F1 · derivative.exercise_date: Option vests in 12 equal monthly installments beginning June 19, 2020. Read SEC document |
| May 19, 2020 Filed May 21, 2020 22:57 UTC |
Norwalk Leslie VDirector
|
GrantNon-Qualified Stock Option · Derivative | 6,018 | $0.00 Strike: $119.93 | $0.00 |
DisclosureSEC source: 0001209191-20-031496 · doc4.xml · derivative · entry 1 Norwalk Leslie V · CIK 0001533568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,018 Underlying: Common Stock · 6,018 shares Expires 2030-05-19 F1 · derivative.exercise_date: Option vests in 12 equal monthly installments beginning June 19, 2020. Read SEC document |
| May 19, 2020 Filed May 21, 2020 22:55 UTC |
MORROW GEORGE JDirector
|
GrantNon-Qualified Stock Option · Derivative | 6,018 | $0.00 Strike: $119.93 | $0.00 |
DisclosureSEC source: 0001209191-20-031493 · doc4.xml · derivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,018 Underlying: Common Stock · 6,018 shares Expires 2030-05-19 F1 · derivative.exercise_date: Option vests in 12 equal monthly installments beginning June 19, 2020. Read SEC document |
| May 19, 2020 Filed May 21, 2020 22:52 UTC |
LYONS GARY ADirector
|
GrantNon-Qualified Stock Option · Derivative | 6,018 | $0.00 Strike: $119.93 | $0.00 |
DisclosureSEC source: 0001209191-20-031486 · doc4.xml · derivative · entry 1 LYONS GARY A · CIK 0001123343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,018 Underlying: Common Stock · 6,018 shares Expires 2030-05-19 F1 · derivative.exercise_date: Option vests in 12 equal monthly installments beginning June 19, 2020. Read SEC document |
| May 19, 2020 Filed May 21, 2020 22:42 UTC |
RASTETTER WILLIAM HDirector
|
GrantNon-Qualified Stock Option · Derivative | 6,018 | $0.00 Strike: $119.93 | $0.00 |
DisclosureSEC source: 0001209191-20-031463 · doc4.xml · derivative · entry 1 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,018 Underlying: Common Stock · 6,018 shares Expires 2030-05-19 F1 · derivative.exercise_date: Option vests in 12 equal monthly installments beginning June 19, 2020. Read SEC document |
| May 18, 2020 Filed May 20, 2020 23:15 UTC |
Lippoldt DarinChief Legal Officer
|
Exercise / conversionIncentive Stock Option · Derivative | 5,000 | $32.99 Strike: $32.99 | $164,950.00 |
DisclosureSEC source: 0001209191-20-031033 · doc4.xml · derivative · entry 3 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2025-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option granted February 3, 2015 and vested monthly over four years. Read SEC document |
| May 18, 2020 Filed May 20, 2020 23:15 UTC |
Lippoldt DarinChief Legal Officer
|
SaleCommon Stock | 5,000 | $120.00 | $600,000.00 |
DisclosureSEC source: 0001209191-20-031033 · doc4.xml · nonDerivative · entry 2 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,021 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
| May 18, 2020 Filed May 20, 2020 23:15 UTC |
Lippoldt DarinChief Legal Officer
|
Exercise / conversionCommon Stock | 5,000 | $32.99 | $164,950.00 |
DisclosureSEC source: 0001209191-20-031033 · doc4.xml · nonDerivative · entry 1 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,021 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2020 Filed May 20, 2020 22:59 UTC |
Grigoriadis Dimitri E.Chief Research Officer
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 10,000 | $35.99 Strike: $35.99 | $359,900.00 |
DisclosureSEC source: 0001209191-20-031028 · doc4.xml · derivative · entry 6 Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,588 Underlying: Common Stock · 10,000 shares Expires 2026-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option granted February 5, 2016 and vested monthly over four years. Read SEC document |
| May 18, 2020 Filed May 20, 2020 22:59 UTC |
Grigoriadis Dimitri E.Chief Research Officer
|
SaleCommon Stock | 10,000 | $119.98 | $1,199,800.00 |
DisclosureSEC source: 0001209191-20-031028 · doc4.xml · nonDerivative · entry 2 Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,741 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
| May 18, 2020 Filed May 20, 2020 22:59 UTC |
Grigoriadis Dimitri E.Chief Research Officer
|
Exercise / conversionCommon Stock | 10,000 | $35.99 | $359,900.00 |
DisclosureSEC source: 0001209191-20-031028 · doc4.xml · nonDerivative · entry 1 Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2020 Filed May 15, 2020 00:09 UTC |
Bozigian Haig P.Chief Development Officer
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 18,057 | $0.00 Strike: $81.05 | $0.00 |
DisclosureSEC source: 0001209191-20-029401 · doc4.xml · derivative · entry 12 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,383 Underlying: Common Stock · 18,057 shares Expires 2029-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option granted February 07, 2019 and vests monthly over four years. Read SEC document |
| May 12, 2020 Filed May 15, 2020 00:09 UTC |
Bozigian Haig P.Chief Development Officer
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 15,833 | $0.00 Strike: $81.49 | $0.00 |
DisclosureSEC source: 0001209191-20-029401 · doc4.xml · derivative · entry 11 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,340 Underlying: Common Stock · 15,833 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option granted February 05, 2018 and vests monthly over four years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.